Private Equity, VC & Investor
b2venture vs Breega
Structured technology and market comparison · 2026
Direct Feature Comparison
b2venture · vs · BreegaSwiss venture capital firm backing European technology startups.
European and African early-stage venture capital fund manager.
Analyze all overlapping signals and tech stacks for b2venture and Breega
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between b2venture and Breega?
When comparing b2venture and Breega, both platforms operate within the Private Equity, VC & Investor ecosystem. b2venture is positioned as Swiss venture capital firm backing European technology startups, whereas Breega focuses on European and African early-stage venture capital fund manager. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to b2venture and Breega?
When evaluating b2venture and Breega, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of b2venture and Breega compare?
b2venture is headquartered in CH (founded in 2000) with 10–49 employees. Breega is based in FR (founded in 2013) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: b2venture vs Breega
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
b2venture
Recent Signals
- ·EU-Startups (European Venture)Funding
Ambio raises €5.1 million for recycled plastics platform
Helsinki-based startup Ambio, which develops an AI-native procurement platform for recycled plastics, has raised €5.1 million in a Seed round led by b2venture, with participation from Montis and existing investor Lifeline Ventures. Founded in 2023 by Tommi Bergström and Elmo Pakkanen (former Slush team members), Ambio addresses fragmented supply, inconsistent quality, and manual processes by acting as a principal in transactions, taking responsibility for sourcing, quality assurance, and delivery. The platform combines verified materials, structured quality data, AI-powered matching, and supply chain management, using LLMs to interpret unstructured data. Serving customers in the Nordics, German-speaking Europe, and recently France, the funds will support international expansion and scaling across polymer types, positioning Ambio as the central trust layer and marketplace for recyclates in Europe.
- Ambio raised €5.1 million in a Seed round led by b2venture, with participation from Montis and Lifeline Ventures.
- Founded in 2023 by Tommi Bergström and Elmo Pakkanen (former Slush team members), Ambio develops an AI-native procurement platform for recycled plastics.
- Ambio acts as a principal in transactions, taking responsibility for sourcing, quality assurance, and delivery, and uses AI to predict material quality before sampling.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners b2venture and Breega share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks